Overexpression of SOCS3 exhibits preclinical antitumor activity against malignant pleural mesothelioma.
Iwahori K, Serada S, Fujimoto M, Nomura S, Osaki T, Lee CM, Mizuguchi H, Takahashi T, Ripley B, Okumura M, Kawase I, Kishimoto T, Naka T.
Iwahori K, et al. Among authors: lee cm.
Int J Cancer. 2011 Aug 15;129(4):1005-17. doi: 10.1002/ijc.25716. Epub 2010 Dec 2.
Int J Cancer. 2011.
PMID: 20949562